Brief: Fulcrum Therapeutics Inc Myokardia Terminates Collaboration And License Agreement With Co
March 4 (Reuters) - Fulcrum Therapeutics Inc FULC.O: FULCRUM THERAPEUTICS INC - MYOKARDIA TERMINATES COLLABORATION AND LICENSE AGREEMENT WITH CO FULCRUM THERAPEUTICS INC - TERMINATION EFFECTIVE JUNE 26, 2025 Further company coverage: FULC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fulcrum Therapeutics
See all newsFulcrum Therapeutics, Inc. expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
U.S. STOCKS ON THE MOVE - KBR, Vista Energy, Fulcrum Therapeutics
Fulcrum to merge with Slate in all-stock deal after drug setback